Stock Events

Stock Events

Global Pharmatech 

$0.070000
2
+$0.00+0% Tuesday 20:00

Statistics

Day High
0.07
Day Low
0.07
52W High
0.106
52W Low
0.05
Volume
25
Avg. Volume
526
Mkt Cap
29.06M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30JunExpected
Q3 2006
Q4 2006
Q1 2007
Q2 2007
Q3 2007
Q4 2007
Q1 2008
-0.06
-0.04
-0.02
-0
Expected EPS
N/A
Actual EPS
-0.0039

Financials

10.91%Profit Margin
Profitable
2021
2022
2023
2024
2025
165,000Revenue
18,000Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is a major player in the pharmaceutical industry, directly competing in several therapeutic areas that Global Pharmatech targets.
Merck
MRK
Mkt Cap366B
Merck operates globally in the pharmaceutical sector, offering innovative medicines and vaccines that compete with Global Pharmatech's products.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson offers a broad range of health care products. Its pharmaceutical division competes with Global Pharmatech in multiple drug categories.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline focuses on a wide array of pharmaceutical products, directly competing with Global Pharmatech in the areas of respiratory diseases and vaccines.
Novartis
NVS
Mkt Cap292.35B
Novartis is known for its innovative medicines and directly competes with Global Pharmatech in several key therapeutic areas.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie operates in various therapeutic areas, including immunology and oncology, where Global Pharmatech also has significant investments.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol-Myers Squibb is a major pharmaceutical company that competes with Global Pharmatech in the fields of cancer and cardiovascular diseases.
Sanofi
SNY
Mkt Cap107.39B
Sanofi produces a range of pharmaceutical products that compete across several of the same therapeutic areas as Global Pharmatech.
Lilly(Eli) &
LLY
Mkt Cap1.05T
Eli Lilly and Company offers products in oncology, diabetes, and neurodegeneration, competing with Global Pharmatech's product lines.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca is involved in the development and manufacturing of pharmaceutical products in areas like oncology, cardiovascular, renal, and metabolism, competing with Global Pharmatech.

About

Global Pharmatech, Inc. engages in the discovery, development, manufacturing, and marketing of proprietary drugs developed based on traditional Chinese medicine. Its operations are based in the People's Republic of China with sales distribution in China, Singapore, Malaysia, Indonesia, and USA. The company was founded on June 26, 2001 and is headquartered in Hong Kong.
Show more...
CEO
Mei Sheng Liao
Employees
217
Country
United States
ISIN
US37945N1090

Listings

OTC Link
US
GBLP

0 Comments

Share your thoughts

FAQ

What is Global Pharmatech stock price today?▼
The current price of GBLP is $0.07 USD — it has increased by +0% in the past 24 hours. Watch Global Pharmatech stock price performance more closely on the chart.
What is Global Pharmatech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Global Pharmatech stocks are traded under the ticker GBLP.
What is Global Pharmatech market cap?▼
Today Global Pharmatech has the market capitalization of 29.06M
What were Global Pharmatech earnings last quarter?▼
GBLP earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Global Pharmatech revenue for the last year?▼
Global Pharmatech revenue for the last year amounts to 165,000 USD.
What is Global Pharmatech net income for the last year?▼
GBLP net income for the last year is 18,000 USD.
How many employees does Global Pharmatech have?▼
As of September 04, 2026, the company has 217 employees.
In which sector is Global Pharmatech located?▼
Global Pharmatech operates in the Health & Wellness sector.
When did Global Pharmatech complete a stock split?▼
Global Pharmatech has not had any recent stock splits.
Where is Global Pharmatech headquartered?▼
Global Pharmatech is headquartered in Hong Kong, United States.